Samsung shares could rise 50% as chip business…

Samsung Galaxy Z Fold 2SamsungAnalysts are bullish on Samsung after the company unveiled a foldable phone on Tuesday and U.S. semiconductor company Nvidia said its next-generation gaming chip will be manufactured by the South Korean…

Chingari, Zoho among some winners of govt App…

The government has announced the winners along with some of the top contestants under its programme to incentivise homegrown applications under the Atmanirbhar mission of the Indian government. Under the App Innovation Challenge, while Indian…

Dispatches from a Pandemic: Brazilian doctors fume as…

Brazilian doctors are fuming, joining growing ranks of furious compatriots, about President Jair Bolsonaro’s widely criticized mishandling of the country’s coronavirus crisis just as businesses begin to reopen despite rising deaths. “Yes, it’s Bolsonaro’s fault,”…

Yes Bank gets bourses approval for re-classification of…

MUMBAI Private sector lender Yes Bank on Friday said it has received approval of leading bourses BSE and National Stock Exchange for re-classification of the promoter shareholding. Part of shareholding classified as "promoter shareholding" now…

RIL on a deal spree, gets eighth cheque…

MUMBAI: Oil-to-telecom conglomerate Reliance Industries (RIL) said on Sunday it has received its eighth investment for Jio Platforms with the Abu Dhabi Investment Authority (ADIA) signing up to buy 1.16 per cent stake for an…

RIL gets its seventh cheque for Jio Platforms,…

Mumbai: Mukesh Ambani-led Reliance Industries said late on Friday it has received a seventh investment in its Jio Platforms in the last six weeks, this time again from US private equity firm Silver Lake Partners.…

RIL gets fourth cheque in four weeks, General…

New Delhi: Reliance Industries-owned Jio Platforms grabbed another cheque from General Atlantic, a leading global growth equity firm, worth Rs 6,598.38 crore for 1.34 per cent in the company. This investment values Jio Platforms at…

Gilead gets emergency FDA authorization for remdesivir to…

The Food and Drug Administration has granted emergency use authorization for Gilead Sciences remdesivir drug to treat the coronavirus, President Donald Trump announced Friday.Trump made the announcement in the Oval Office alongside Gilead CEO Daniel O'Day."We…